T-REX Acquisition Corp. (TRXA): Warrant Overhang and Dilution Risks for Small-Cap Investors

T-REX Acquisition Corp. (TRXA) carries a 6.3% dilution risk from its 1.9 million outstanding warrants, a significant overhang for a company with a $15.4M market cap. This level of dilution exposure raises red flags for investors, particularly given TRXA’s status as a pre-revenue SPAC and its lack of a current stock price ($N/A). The warrants—covering 6.3% of the float—could severely depress shareholder value if exercised, especially in a scenario where the company’s valuation improves.

### Warrant Terms and Dilution Exposure

TRXA’s 1.9 million warrants represent 6.3% of the company’s total shares outstanding, assuming full exercise. For context, this means every shareholder would experience a 6.3% reduction in ownership if all warrants are converted into common stock. With a $15.4M market cap, the theoretical dilution impact would inject ~$970,000 in new capital (assuming warrants are exercised at the current implied price, though no exercise price is disclosed in the provided data). However, the absence of a stock price suggests TRXA may be delisted or trading in a non-liquid market, complicating assessments of warrant exercisability.

SPACs like TRXA often issue warrants as part of their IPO process, but these instruments can become toxic if the company fails to execute a merger or achieve growth milestones. Unlike traditional equity, warrants only provide value if the stock price exceeds the exercise threshold—a condition that appears unlikely for TRXA given its current market status.

### Acceleration Triggers to Monitor

While specific warrant terms (e.g., exercise price, expiration date) are not included in the data, SPAC warrants typically contain triggers that could force early or accelerated exercises:

1. Business Combination Completion: If TRXA finalizes a merger or acquisition, warrant holders may gain clarity on the stock’s value, prompting exercises if the post-merger price exceeds the strike price.

2. Stock Price Thresholds: Many SPAC warrants become exercisable only if the stock trades above a certain level (e.g., $10–$12 per share). For TRXA, a revival in trading activity and price discovery could activate this clause.

3. Corporate Actions: Amendments to the warrant terms—such as a reduction in the exercise price—could make conversion more attractive.

Without a current stock price or exercise price, it is unclear whether these triggers are imminent. However, the warrants’ existence alone creates a shadow over equity value,